Latest Asx Listing Rules News

Page 4 of 140
Simble Solutions has secured binding commitments for a $1.0 million placement to fund its NanoSensor evaluation program, existing software businesses and working capital. The raise also brings potential option-related dilution and requires shareholder approval for several components.
Victor Sage
Victor Sage
3 Nov 2026
Hawk Resources has acknowledged that historical portable XRF readings underpinning its Olympus scandium story lacked calibration, quality-control and detection-limit records, and were not reliable indicators of scandium grades. The company maintains its original disclosure complied with ASX rules and the JORC Code, but says it will no longer use the historical results.
Maxwell Dee
Maxwell Dee
2 Nov 2026
AMP says it knows of no undisclosed information behind a sharp intraday move in its shares, after ASX questioned a fall from $2.51 to $2.22. The company pointed instead to lower third-quarter profit at China Life Pension Company, while leaving its FY26 partnerships guidance unchanged.
Claire Turing
Claire Turing
2 Nov 2026
4DMedical has denied holding undisclosed information that could explain a sharp sell-off in its shares, after ASX queried a fall from $3.28 to $2.41. The company said it believes increased short interest was responsible and confirmed compliance with continuous disclosure rules.
Victor Sage
Victor Sage
2 Nov 2026
Lithium Plus Minerals has secured A$1.6575 million at A$0.10 a share, with cornerstone backing from Suzhou CATH Energy Technologies and a further A$1 million SPP planned. The funding is aimed at moving the Lei direct shipping ore project into pre-feasibility while supporting resource growth and offtake discussions.
Maxwell Dee
Maxwell Dee
2 Nov 2026
Rokeby Resources has secured $1.3 million through a placement and is seeking a further $1.7 million from eligible shareholders to fund resource estimation, drilling access and working capital. The raise comes at a discount and could materially expand the share count, while attaching options remain subject to shareholder approval.
Maxwell Dee
Maxwell Dee
2 Nov 2026
Enterprise Metals has formalised Phillip Gallagher’s executive chairman appointment and increased the second tranche of its placement to approximately $880,000. The package ties his potential equity incentives to share-price, resource and strategic milestones, but both the placement and incentives require shareholder approval.
Maxwell Dee
Maxwell Dee
30 Oct 2026
US1 Critical Minerals ended September with A$65,000 in cash against quarterly operating outflows of A$406,000, leaving an estimated 0.16 quarters of funding. Its proposed transfer of six Tanzanian uranium licences could provide US$1 million on completion, but remains subject to regulatory and other conditions.
Maxwell Dee
Maxwell Dee
30 Oct 2026
NeuRizer has begun decommissioning plant at Leigh Creek for transport to Reliance Industries’ Indian underground coal gasification projects, while its cash position remains tight and its ASX suspension continues. The company ended September with $1.305 million in cash and estimated 1.4 quarters of funding on current outflows.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Invex Therapeutics has paired its proposed acquisition of Rekover Therapeutics with a $10 million equity raising to fund a Phase 2a multiple sclerosis study and its existing Exenatide programs. The biotech ended September with A$3.59 million in cash, with shareholder approval still required for the larger part of the transaction.
Ada Torres
Ada Torres
30 Oct 2026
Amara Minerals has reported broad gold intersections at its Apollo project in Victoria, including 102.3 metres at 2.29 g/t gold. The exploration momentum comes with just A$0.59 million in quarter-end cash and a stated need to assess further capital raising options.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Australian Dairy Nutritionals has secured firm commitments for a further A$1.54 million placement, taking its broader capital raise to A$2.04 million before costs. The funds are earmarked for operations, working capital and balance sheet support as the company prepares for FY27.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive